Late - Stage Biopharmaceutical Company
Cytokinetics (cytokinetics.com) earns a Brand Analyzer score of 82 out of 100, placing it in the Strong Brand tier among Other brands. Among 6390 Other brands analyzed, Cytokinetics ranks in the 83rd percentile (category average 71, leader 97). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 83/100, Digital Presence 100/100, Visual Identity 92/100, Messaging Clarity 95/100, Trust Foundation 96/100, AI Discoverability 87/100, Brand Authority 39/100.
Cytokinetics is a biopharmaceutical company headquartered in South San Francisco, United States, founded in 1997. The company focuses on muscle biology and is developing potential medicines aimed at improving the healthspan of people living with diseases characterized by impaired muscle function, including cardiovascular and neuromuscular conditions. Cytokinetics combines domain expertise in muscle biology with a research-driven approach to drug development.
| Brand Name | Cytokinetics |
|---|---|
| Domain | cytokinetics.com |
| Industry | Other |
| Founded | 1997 |
| Headquarters | South San Francisco |
| Main Competitors | MyoKardia, Bristol Myers Squibb (84/100), Amgen (82/100), Tenaya Therapeutics, Imbria Pharmaceuticals, Sarepta Therapeutics (83/100), Ionis Pharmaceuticals (79/100) |
Moz Domain Authority 48/100 vs category average 34 / leader 94 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #672,034 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Cytokinetics has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Cytokinetics is committed to developing potential medicines for people with diseases of impaired muscle function. Learn more about our medicines and research." (Meta description: 22 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), LinkedIn, YouTube, Instagram; no detected presence on Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Cytokinetics scores 58/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Cytokinetics has a limited AI-visibility profile at 58/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (68/100) and its weakest is trust (36/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #672,034 (Tranco). The main gaps holding it back: no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Cytokinetics from memory (August 2026) - a sign these signals are paying off.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is Cytokinetics?", Claude could identify the brand as of August 2026. Cytokinetics is a biopharmaceutical company focused on muscle biology, developing drugs that target cardiac and skeletal muscle function to treat conditions like heart failure and neuromuscular diseases. Its lead programs include omecamtiv mecarbil and aficamten, cardiac myosin m Best known for Developing cardiac myosin activators/inhibitors, notably aficamten for hypertrophic cardiomyopathy and omecamtiv mecarbil for heart failure.
When asked "Best brands similar to Cytokinetics?", Claude would recommend Cytokinetics as of August 2026. It's a notable name in cardiovascular-focused biotech with a distinctive muscle mechanics drug discovery platform, worth mentioning alongside other cardiology-focused biopharma companies.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Cytokinetics's main competitors include MyoKardia, Bristol Myers Squibb (84/100), Amgen (82/100), Tenaya Therapeutics, Imbria Pharmaceuticals. These companies compete in the Other space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
Cytokinetics and Bristol Myers Squibb are competitors in Other. Brand Analyzer scores Cytokinetics at 82/100 and Bristol Myers Squibb at 84/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to Cytokinetics include MyoKardia, Bristol Myers Squibb (84/100), Amgen (82/100), Tenaya Therapeutics, Imbria Pharmaceuticals. Each is an established option in the Other space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
Cytokinetics has moderate AI-search visibility, scoring 58/100 on Brand Analyzer's AI visibility composite (visibility 68, trust 36, recommendation 65). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Cytokinetics official site
Cytokinetics was founded in 1997. Cytokinetics operates in the Other category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Cytokinetics is headquartered in South San Francisco. Cytokinetics operates in the Other category.
Sources: Wikidata
Cytokinetics scores 65/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Other options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Cytokinetics official site
Cytokinetics is a biopharmaceutical company headquartered in South San Francisco, United States, founded in 1997. It specializes in muscle biology and is dedicated to developing potential medicines for people with diseases of impaired muscle function.
Sources: Cytokinetics official site
Cytokinetics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Cytokinetics official site
Cytokinetics researches and develops potential medicines targeting diseases of impaired muscle function. The company applies its expertise in muscle biology to create therapeutic candidates intended to improve the healthspan of patients affected by such conditions, which can include cardiovascular and neuromuscular diseases.
Sources: Cytokinetics official site
Cytokinetics is known for its focus on muscle biology and its efforts to develop potential medicines for diseases characterized by impaired muscle function, positioning itself as a company with deep domain expertise in this therapeutic area.
Sources: Cytokinetics official site
Ranked closest to Cytokinetics: Coverall (82/100), Reworld™ (82/100), Dating.com (82/100), Davey Tree (82/100).
A step up - brands to learn from: Taskrabbit (91/100), SUEZ (91/100).
Category leader: Accenture (97/100).